ARK Genomic Revolution ETF ARKG
45.45 USD +0.83 (+1.86%)
At closeNov 9, 2026, 5:31 AM EST
45.86 +0.41 +0.89%
Pre-market · Nov 9, 5:31 AM ET
43.90 Day range 45.92
24.60 52-week range 58.83
- YTD
- +56.89%
- 1 year
- +60.26%
- Market cap
- 1.59B
- YTD return
- +56.89%
- 1-year return
- +60.26%
- Volume
- 4.01M
- Avg volume
- 4.91M
- Open
- 44.54
- Previous close
- 44.62
- Day's range
- 43.90 – 45.92
- 52-week range
- 24.60 – 58.83
1Y +17.42 (+62.15%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 39.68
- 200-day average
- 32.15
About ARK Genomic Revolution ETF
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ARKG — it syncs with the Stock Master app.